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Summary 
 
Various percentages (1.2% to 13%) of β-
cyclodextrin (β–CD) were added to water or 
pasteurized whole milk to study β-CD crystal-
lization patterns.  Influential factors such as 
crystallization time (4 to 12 h), crystallization 
temperature (45º vs. 72ºF), and centrifugation 
speed (25 to 3000 × g) were investigated.  Op-
timized crystallization conditions were veri-
fied in antibiotic-tainted raw milk samples via 
the enzyme-linked receptor-binding assay and 
by solids partitioning.  In water, β-CD precipi-
tate increased significantly as β-CD concen-
tration and crystallization time increased, but 
was independent of the centrifugation speed.  
In pasteurized whole milk, precipitate in-
creased as β-CD concentration, crystallization 
time, and centrifugation speed increased.  The 
best β-CD precipitation conditions in milk 
were designated as: 9.1% β-CD concentration 
(w/w), 4 hour crystallization time, 45ºF, and 
centrifugation at 25 × g for 10 minutes.  
Eleven cows were treated with cephapirin so-
dium or cephapirin benzathine.  Milk was ob-
tained 12 h later and treated with β-CD.  As β-
CD concentrations increased, precipitates in-
creased, and the corresponding supernatants 
showed reduced concentrations of antibiotics 
when tested by enzyme-linked receptor-
binding assay.  Results indicated that β-CD 
may have the potential to reduce the residues 
of cephapirin sodium or cephapirin benzathine 
in antibiotic-tainted raw milk.  
 
(Key Words: β-cyclodextrin, Cephapirin So-
dium, Cephapirin Benzathine, Milk.) 
 
 
 
Introduction 
 
Cyclodextrins are chemically and physi-
cally stable molecules formed by the enzy-
matic modification of starch.  β-Cyclodextrin 
(β-CD) is a cyclic oligosaccharide having a 
cavity at the center of its molecular arrange-
ment that allows for inclusion-complexing 
with various compounds.  Of all the cyclodex-
trins, β-CD has limited aqueous solubility of 
1.85 g/100 mL at 77°F.  Previous work has 
shown that β-CD can bind cholesterol from 
various food sources, such as milk, and thus, 
lower the cholesterol content in the liquid por-
tion of the food. 
 
Antibiotics are used to treat bacterial in-
fections in humans and animals.  Bovine mas-
titis is an inflammatory and highly communi-
cable udder disease, which is often treated 
with the administration of antibiotics.  The 
most common antimicrobials used in lactating 
cows are the group known as β-lactams (e.g., 
cephalosporins and penicillins).  Antibiotics 
can enter the raw milk supply when milk from 
antibiotic-treated cows is inadvertently mixed 
with that from healthy cows.  If humans sensi-
tive to these drugs consume the antibiotic-
tainted milk, they may exhibit allergic reac-
tions that range from mild skin rashes to life-
threatening anaphylaxis.  Studies showed that 
penicillin may produce allergic reaction when 
its concentration is as small as 10 ppb in milk.  
In the United States, testing of each incoming 
milk shipment is mandatory; in 2002 alone, 
the United States disposed of 85.5 million lb 
of milk because of the presence of antibiotics.  
As of now, no tested and proven method 
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has been developed to remove these poten-
tially harmful compounds from milk. 
 
The β-Lactam drugs have structures simi-
lar to other organic compounds such as cho-
lesterol (molecular size: Cephalosporin - 
478.7; Cholesterol - 414.7).  β-CD complexes 
may be precipitated under certain conditions, 
such as heating then cooling, to remove un-
wanted compounds from liquid solutions.  The 
test hypothesis was to study the crystallization 
pattern of β-CD in water and to determine 
whether β-CD can complex and precipitate 
unwanted antibiotic residues in raw milk. 
 
Experimental Procedures 
 
Pharmaceutical grade β-CD (Wacker Bio-
chem Corp. Adrian, MI), pasteurized whole 
milk (Kansas State University dairy plant, 
Manhattan, KS), and raw milk (Kansas State 
University Dairy Teaching and Research Cen-
ter, Manhattan, KS) were obtained.  
 
Solutions were made with 20 g of solvent 
(pasteurized whole milk or deionized distilled 
water) and a variety of concentrations (1.2, 
2.4, 4.8, 9.1, or 13%) of β-CD (w/w).  Solu-
tions were stirred continuously at 500 rpm for 
10 minutes at 140°F to allow for complete dis-
solution of β-CD. 
 
Some solutions were held at 72 ± 2°F for 5 
or 10 h to allow for precipitation.  After crys-
tallization, solutions were transferred into 50-
mL centrifuge bottles and centrifuged at 25, 
50, 100, 250, 500, 1000, 2000, or 3000 × g for 
10 minutes at 22 ± 2°F.  Other solutions were 
placed in capped centrifuge bottles immedi-
ately after mixing and heating, and were trans-
ferred to an ice bath (32 ± 2°F) to achieve a 
solution temperature less than or equal to 50°F 
within 20 minutes.  After 20 minutes in the ice 
bath, centrifuge bottles were transferred to 
storage (45°F) and maintained for 4, 5, 8, or 
12 h.  Solutions held at refrigerated conditions 
were centrifuged at 25 × g for 10 minutes.  
Total solids for β-CD, raw milk, pasteurized 
whole milk, supernatants, and precipitates 
were performed as outlined in standard meth-
ods. 
 
Antibiotic-infused milk was obtained from 
K-State Dairy Teaching and Research Center 
12 h after antibiotic administration.  Two dif-
ferent β-lactam drugs (10 mL), cephapirin so-
dium or cepharpirin benzathine, were infused 
into all four quarters of 5 or 6 cows, respec-
tively.  Milks were tested by using an enzyme-
linked receptor-binding assay (ELRBA) ap-
proved by the FDA for the rapid assay for 
presence of antibiotic in milk.  Antibiotic-
tainted milk was diluted with raw, bulk tank 
milk to obtain ratios that might occur when 
milk from an antibiotic-treated cow was inad-
vertently mixed with normal milk.  Milk sam-
ples were then treated with β-CD, heated to 
72°F, cooled, refrigerated, and then centri-
fuged for 10 minutes at 25 × g.  Supernatants 
were retrieved and tested for antibiotic pres-
ence with the ELRBA test.   
 
Three experiments were conducted.  In the 
first experiment, the crystallization pattern of 
β-CD in water as a function of centrifugation 
speed and β-CD solution concentration was 
studied.  A simple 2-factorial design was used 
with various β-CD concentrations (1.2 to 
13.1%), and centrifugation speeds (1000 to 
3000 × g).  Crystallization patterns were 
evaluated by monitoring β-CD in the precipi-
tate and supernatant.  The second experiment 
focused on the effect of centrifugation speed 
on the precipitate recovery of β-CD in water 
solutions.  A simple 1-factorial design com-
paring five centrifugation speeds (25, 50, 100, 
250, and 500 × g) at a single β-CD concentra-
tion (9.1% w/w) was used.  The same experi-
ment was repeated with pasteurized whole 
milk as the diluent.  In the third experiment, 
crystallization patterns of β-CD in water and 
pasteurized whole milk at 45°F as a function 
of holding time were determined by using a 
randomized block design with replication as 
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the blocking factor and holding time (4, 5, 8, 
and 12 h) as the main factor, keeping a con-
stant concentration of 9.1% β-CD.  Finally, to 
validate our data, antibiotic-tainted milk was 
obtained from 11 cows and was treated with 
β-CD and subsequently analyzed for the pres-
ence of antibiotics. 
 
Results and Discussion 
 
The main effects and interaction of β-CD 
and centrifugation speed were significant for 
total solids in the precipitate and in the super-
natant.  Table 1 summarizes average total sol-
ids for the precipitate and supernatant.  The 
results illustrate the solubility characteristics 
of β-CD.  Table 1 clearly shows that, at a β-
CD concentration of 1.2% (less than the solu-
bility limit), no solids were recovered in the 
precipitate. In contrast, at the greater concen-
tration of 2.4%, a small amount of solids 
(11.4%) was recovered in the precipitate.  
When concentrations exceeded the β-CD 
solubility range, greater amounts of total sol-
ids were recovered in the precipitate (Table 1).  
For the 9.1% solution, precipitate recovery 
was independent of the centrifugation speed.  
 
When considering the final objective of 
using β-CD to complex β-lactam antibiotic, 
and subsequently precipitate the complex, two 
conditions were thought to be important: 1) 
choose a β-CD concentration that is sufficient 
to complex with β-lactam; and 2) use condi-
tions to maximize β-CD+β-lactam complex 
precipitation with minimal expenditures of 
energy and cost.  Table 1 indicates that the 
greatest precipitate recovery occurred at the 
13% concentration, but the difference between 
the 9.1% and 13% concentration was rela-
tively small (70% vs. 75%). Therefore, a 9.1% 
concentration of β-CD was selected for further 
work to maximize complexing and recovery 
of the contaminant in the precipitate.  
 
To verify whether centrifugation speed af-
fected precipitate recovery, a range of cen-
trifugation conditions (25 to 3000 × g) were 
selected.  Results from various centrifugation 
speeds (Figure 1 and Table 2) illustrate that 
recovery of precipitate was independent of 
speed when water was the diluent.  When milk 
was the diluent, amount of precipitate in-
creased as centrifugation speed increased, in-
dicating that the centrifugation procedure 
caused some of the milk solids to precipitate.  
To minimize milk solids in the precipitate, the 
slowest centrifugation speed (25 × g) was se-
lected for further experiments. 
 
To enhance the crystallization rate of β-
CD and maintain the milk at refrigerated con-
ditions, solutions of β-CD with water or raw 
milk were held at 45°F for 4, 5, 8, or 12 h.  
Results indicated that the main effects and in-
teractions of β-CD holding time were signifi-
cant for the total solids in the precipitate.  In 
contrast, for the supernatant solids, the 9.1% 
solution did not show a difference.  Table 3 
shows the results of total solids in the super-
natant and precipitate portion for raw milk or 
water.  As the holding time increased, total 
solids in the precipitates of the milk also in-
creased (P<0.05; Table 3).  At 4 h, raw milk 
had minimum solids in the precipitate.  Pre-
cipitate recoveries in milk exceeded the 
amount of added β-CD (at 12 h), indicating 
that milk solids were being precipitated with 
β-CD (Table 3).  The difference of total solids 
in the water and milk precipitate was reported 
as loss of milk solids in milk precipitate.  A 
holding time of 4 h was considered best for 
raw milk and was used as a standard holding 
time in future experiments to minimize losses 
of milk solids in the precipitate.  
 
To test that hypothesis raw milk was ob-
tained from mastitic cows 12 h after treatment 
with either cephapirin sodium or cephapirin 
benzathine.  For brevity, results from two 
cows are presented herein.  Initial results indi-
cated that antibiotic presence was high, so 
various amounts of β-CD were added to the 
raw milk, dissolved, and precipitated, and the 
resultant milk supernatant was tested for the 
presence of antibiotics.  The ELRBA values 
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indicated that as β-CD concentration in-
creased, ELRBA value decreased, and some to 
the point of the milk being considered nega-
tive for residue (Table 4).  This study provides 
some evidence that the β-CD may be able to 
complex and then precipitate unwanted β-
lactam drugs in raw milk. 
 
In water, β-CD precipitate increased as β-
CD concentration increased, but the amount of 
precipitate was independent of centrifugation 
 
speed.  In raw milk, the total solids in the pre-
cipitate increased with the increased β-CD 
concentration and with crystallization time.  
Optimal conditions for the β-CD precipitation 
in milk was 9.1% β-CD concentration (w/w), 
4 h crystallization time at 45ºF, and centrifu-
gation at 25 × g for 10 minutes.  Results from 
ELRBA indicated that β-CD has the potential 
to reduce the residues of cephapirin sodium or 
cephapirin benzathine in antibiotic-tainted raw 
milk. 
 
 
 
 
 
Table 1.  Total Solids in Precipitate and Supernatant from Solutions of De-ionized Distilled 
Water and 1.25 to 15% (0.25 to 3 g) β-Cyclodextrin, Centrifuged at 1000, 2000, or 3000 × g 
for 10 Minutes 
 Precipitate1, g 
β-cyclodextrin 1000 × g 2000 × g 3000 × g 
0.25 g (1.2%) 0.00 + 0.00g 0.00 + 0.00g 0.00 + 0.00g 
0.50 g (2.4%) 0.06 + 0.01f 0.06 + 0.02f 0.05 + 0.02f 
1.00 g (4.8%) 0.51 + 0.02d 0.48 + 0.02e 0.47 + 0.03e 
2.00 g (9.1%) 1.39 + 0.02c 1.39 + 0.01c 1.39 + 0.02c 
3.00 g (13%) 2.21 + 0.02b 2.27 + 0.01a 2.27 + 0.01a 
 Supernatant1, g 
β-cyclodextrin 1000 × g 2000 × g 3000 × g 
0.25 g (1.2%) 0.21 ± 0.01k 0.21 ± 0.01k 0.22 ± 0.01k 
0.50 g (2.4%) 0.38 ± 0.02e,f 0.37 ± 0.02f,g,h 0.38 ± 0.01e,g 
1.00 g (4.8%) 0.46 ± 0.01a,b,c 0.48 ± 0.03a 0.47 ± 0.02a,b 
2.00 g (9.1%) 0.45 ± 0.02b,c 0.43 ± 0.02c,d 0.37 ± 0.02f,g,i 
3.00 g (13%) 0.40 ± 0.01d,e 0.35 ± 0.01h,i,j 0.34 ± 0.01j 
a,b,c,d,e,f,g,h,i,j,kMeans having different superscript letters within columns and rows for either pre-
cipitate or supernatant differ (P<0.05). 
1Mean and standard deviations (n = 3). 
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Table 2.  Total Solids in Supernatant and Precipitate of De-ionized Distilled Water having 
2g of β-Cyclodextrin and Centrifuged at 25, 50, 100, 250, or 500 × g for 10 Minutes 
Force (× g) Supernatant1 Precipitate1 
25 0.40 ± 0.06b 1.36 ± 0.06a 
50 0.41 ± 0.07b 1.36 ± 0.06a 
100 0.35 ± 0.01b 1.40 ± 0.01a 
250 0.39 ± 0.00b 1.35 ± 0.02a 
500 0.39 ± 0.02b 1.39 ± 0.00a 
a,bMeans having different superscript letters within a column differ (P<0.05). 
1Data represents mean ± SD (n = 3). 
 
 
Table 3.  Precipated Total Solids in De-ionized Distilled Water or Raw Milk Treated with 2 
g of β-Cyclodextrin, Held at 45° for 4, 5, 8, or 12 Hours, and Centrifuged at 25 × g for 10 
Minutes 
Time Raw milk1 Water1 Difference 
4 hours 1.72 ± 0.24b 1.46 ± 0.03d 0.26 
5 hours 1.98 ± 0.33a,b 1.48 ± 0.03c 0.50 
8 hours 1.97 ± 0.31a,b 1.51 ±  0.03b 0.46 
12 hours 2.03 ± 0.22a 1.53 ±  0.02a 0.50 
a,b,c,dMeans having different superscipts within a column differ (P<0.05). 
1Mean ± SD. 
 
 
Table 4.  ELRBA Values of Antibiotic-tainted Raw Milk, Before and After Treatment with 
0, 1, 2, or 4 g of β-Cyclodextrin 
Antibiotic 
ELRBA before 
treatment 
Amount of 
β-Cyclodextrin, g 
ELRBA after 
treatment 
Cephapirin sodium 2.26 (positive) 0 2.19 (positive) 
  1 1.35 (positive) 
  2 0.93 (negative) 
  4 0.89 (negative) 
 
Cephapirin benzathine 
 
1.26 (positive) 
 
0 
 
1.13 (positive) 
  1 1.08 (positive) 
  2 0.98 (negative) 
  4 0.91 (negative) 
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Figure 1.  Total Solids in Precipitate of De-ionized Distilled Water and Milk Treated with 2 
g of β-Cyclodextrin, Held at 72 ± 2°F, and Centrifuged at 25, 50, 100, 250, or 500 × g.  
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